SXTC

Healthcare Drug Manufacturers - Specialty & Generic

China SXT Pharmaceuticals, Inc.

$1.95

-0.01 -0.51% today Live

Price History

Not enough data

Price chart data
Date	Price
Oct 7, 2026, live at 11:04 AM ET	1.95

Key Stats

Market Cap

2.58M

Avg Volume

1.42M

EPS

-$730.40

52W High

$83,760.00

52W Low

$1.18

Div. Yield

0.0%

Valuation

P/B Ratio

0.00

P/S Ratio

2.26

EV/EBITDA

3.79

EV/Revenue

-23.46

Margins

Gross Margin 21.9%

Operating Margin (153.3%)

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Revenue Growth (YoY)

(43.9%)

Return on Equity

(27.5%)

Return on Assets

(15.8%)

Liquidity & Leverage

Current Ratio

7.93

Quick Ratio

7.23

Debt / Equity

0.04

Total Cash

28.32M

Total Debt

1.12M

About

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers Advanced TCMP, including Directly-Oral-TCMP, and After-Soaking-Oral TCMP; Fine TCMP and Regular TCMP products; and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.